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Introduction
Diabetes mellitus type 2 (DM2) is a metabolic disease that
involves complex multifactorial genetic and environmental
factors [1]. Studies on the molecular genetics has sug-
gested that many genes may be important in susceptibility
to DM26. Recently, large-scale studies such as genome-
wide associations studies (GWAS) have shown several
important genes associated with T2DM. Among these
genes, one of the most strongly associated with the disease
is TCF7L2. This gene has many polymorphisms described,
however the majority of studies indicate variants
rs7903146 and rs12255372 as the most important within
this gene.
Methodological procedures
The sample consisted of 61 adults diagnosed with T2DM,
from in the SIS-Hiperdia patient follow-up program. This
is characterized as a continuing research entitled: “Identifi-
cation of risk factors in diabetic and hypertensive users and
nonusers of herbal Bauhinia forficata (paw-of-cow) regis-
tered in the SIS program Hiperdia/MS from 2009 to 2010,
at the 16th Regional Health/RS”. We analyzed some bio-
chemical markers such as glucose, glycated hemoglobin
(HbA1C) and C-reactive protein (CRP) using a Mindray
BS120 analyzer. The variant rs7903146 (C/T) and
rs12255372 (G/T) of the TCF7L2 gene were genotyped by
Real Time PCR. A significance level of 5%.was used to
declare associations. The study was approved by the
Research Ethics committee at UNIVATES under number
110/11.
Results and discussion
There were 61 subjects, of which 43 (70.5%) were female
and 18 (29.5%) males. It was found that the T allele fre-
quency was 0.34 and 0.33 respectively for the rs7903146
and rs12255372. The genotypic frequencies are in agree-
ment with the expected Hardy- Weinberg equilibrium.
According to Wilfred et al (2012) [2] the risk allele T
(rs7903146) is strongly associated with the risk of T2DM,
especially in Caucasians. Studies also show that carriers of
the risk allele exhibit increased levels of some inflamma-
tory markers such as CRP and Hb1Ac [3]. In our study,
no significant associations were detected between the var-
iants analyzed and the biochemical variables (glucose:
rs7903146 p = 0.92, p = 0.96 rs12255372, Hb1Ac:
rs7903146 p = 0.16, p = 0.09 and rs12255372 CRP:
p = 0.50 rs7903146, rs12255372 p = 0.39)
Conclusion
Studies indicate that the presence the T allele in these
polymorphisms can influence in the risk of development
and gravity of the T2DM. However, in this study, the
allele T was not associated to outcomes biochemical in
individuals with DM2. Failure to observe any significant
result does not exclude the role of the gene as a modu-
lator of disease severity.
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Table 1 Association of TCF7L2 gene polymorphism and inflammatory markers in DM2
SNP
TCF7L2
Genotype # Glucose Hb1AC CRP
Level p value Level p value Level p value
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